Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-16

Clinical Trial Update: Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating the efficacy and safety of polidocanol injectable foam for treating saphenofemoral junction incompetence in varicose veins.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polidocanol injectable foam (polidocanol)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Varicose Veins | Phase 3 | Status: COMPLETED | Results posted: 2014-05-16